Generic Eloxatin Suspension Makes At Risk Launches A Little Riskier
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva and Hospira halt shipments of oxaliplatin after an appeals court temporarily stays FDA approval of their ANDAs.